Jump Financial, LLC Revolution Medicines, Inc. Transaction History

Jump Financial, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 21, 2024	BUY	$25.17 - $35.05 $382,810 - $533,075	15,209 New	15,209 $420,000
Q3 2023 Nov 07, 2023	BUY	$25.17 - $35.05 $382,810 - $533,075	15,209 New	15,209 $420,000
Q4 2022 Feb 13, 2023	BUY	$17.68 - $25.53 $485,422 - $700,951	27,456 New	27,456 $654,000
Q2 2022 Aug 09, 2022	SELL	$14.54 - $27.17 $58,160 - $108,680	-4,000 Reduced 5.9%	63,800 $1.24 Million
Q1 2022 May 12, 2022	BUY	$17.31 - $26.4 $759,909 - $1.16 Million	43,900 Added 183.68%	67,800 $1.73 Million
Q4 2021 Feb 10, 2022	BUY	$24.35 - $33.7 $581,965 - $805,430	23,900 New	23,900 $602,000
Q1 2021 May 17, 2021	SELL	$37.21 - $54.43 $521,535 - $762,890	-14,016 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$30.19 - $45.49 $423,143 - $637,587	14,016 New	14,016 $555,000

266

161M

260K

620K

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.8B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.